We have previously reported that ASO-mediated reduction of branch-specific NMD factor UPF3B upregulated PTC-containing mRNAs while having minimal impact on the transcriptome in a hemophilia mouse model21, which provides evidence that targeting branch-specific NMD factors could be both a safe and effective strategy for targeting nonsense mutations in the disease context. This evidence concerns the gene UPF3B and hemophilia.